Springer to publish Nuclear Medicine and Molecular Imaging

Journal Nuclear Medicine and Molecular Imaging now available on SpringerLink

NMMI publishes original research papers, reviews, case reports, editorials and letters to the editor on nuclear medicine and a wide range of related sciences. These include radiochemistry, radiopharmacy, dosimetry and pharmacokinetics/pharmacodynamics of radiopharmaceuticals, nuclear and molecular imaging analysis, nuclear and molecular imaging instrumentation, radiation biology and radionuclide therapy. June-Key Chung, MD, PhD, from the Seoul National University College of Medicine will serve as editor-in-chief. He will be supported by an international editorial board.

"We hope to share our experience, knowledge and vision with global colleagues through NMMI. Thanks to the new cooperation with Springer, we will be able to communicate with scientists and physicians from Europe, America and Africa, discussing topics with experts everywhere to establish standards," expresses Hee-Seung Bom, MD, PhD, President of the Korean Society of Nuclear Medicine, in his Editorial which will be published in Issue 1 of Volume 44.

Ute Heilmann, PhD, Editorial Director, Clinical Medicine at Springer, said, "We are delighted that Nuclear Medicine and Molecular Imaging will be a part of Springer's publishing program. Korean articles in the field of nuclear medicine and radiology are well known worldwide for their high quality - this adds great value to our portfolio in this field."

Springer will publish Nuclear Medicine and Molecular Imaging in both print and electronic formats, starting with Volume 44, Issue 1. The journal will be available via www.springerlink.com, Springer's online information platform. It will include fast, electronic publication in Online First-, as well as Cross Reference Linking and Table of Contents Alerts.